Literature DB >> 10697917

Malignant colorectal tumours in patients 30 years and below: a review of 35 cases.

A Z Sule1, B M Mandong.   

Abstract

OBJECTIVE: To review malignant colorectal tumour arising in patients 30 years and below.
DESIGN: Retrospective cross sectional descriptive study.
SETTING: Jos University Teaching Hospital, Jos, Nigeria.
SUBJECTS: A total of 35 patients 30 years and below. MAIN OUTCOME MEASURES: Occurrence of malignant colorectal tumours tends to be higher among men and women over age 65 years and more common among Whites than Blacks. The disease rarely presents in the young population and the prognosis is usually unfavourable. This may be due to a delay in the diagnosis because colorectal cancer is not usually considered first in this age group.
INTERVENTIONS: 15 patients had abdomino-perineal excision of the rectum, two right hemicolectomy, one left hemicolectomy, two anterior resection and six had colostomy and biopsy.
RESULTS: Altogether, 149 patients were treated for large bowel cancer. From then, 35 (23.6%) given a yearly incidence of 3.5 were 30 years old or younger. The mean age was 25 (STD +/- 6) years, while the M:F ratio was 1.2:1. Weight loss, bloody mucoid diarrhoea, tenesmus and an anorectal mass were common clinical features present for more than six months. The rectum was involved in 24 patients (68.6%) and adenocarcinoma either well/moderately well differentiated or poorly differentiated was the predominant histological type. All the cancers except four were advanced at first presentation and treatment was merely palliative with only 30% of those treated and followed up still alive at six months. Complications of surgery were considered minor with the exception of the pelvic abscesses and deaths were due to the effects of the disease.
CONCLUSIONS: This study illustrates that colorectal cancer is not rare, as it was previously believed. Presentation is commonly late and prognosis poor. In this age group, malignant colorectal tumours should frequently be considered in the differential diagnosis of bowel symptoms. The importance of the prudence of the general practitioner is thus emphasized.

Entities:  

Mesh:

Year:  1999        PMID: 10697917     DOI: 10.4314/cajm.v45i8.8486

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  5 in total

1.  The influence of the design of mandibular major connectors on gingival health.

Authors:  T J Ogunrinde; O O Dosumu; O P Shaba; P A Akeredolu; M D Ajayi
Journal:  Afr J Med Med Sci       Date:  2014-03

2.  Colorectal carcinoma in Lagos and Sagamu, Southwest Nigeria: a histopathological review.

Authors:  Fatimah-Biade Abdulkareem; Emmanuel-Kunle Abudu; Nicholas-Awodele Awolola; Stephen-Olafimihan Elesha; Olorunda Rotimi; Olakanmi-Raphael Akinde; Ayoola-Oluwole Atoyebi; Adedoyin-Adekunle Adesanya; Adetola-Olubunmi Daramola; Adekumbiola-Aina-Fehintola Banjo; Charles-Chidozie Anunobi
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

3.  Clinicopathological patterns and challenges of management of colorectal cancer in a resource-limited setting: a Tanzanian experience.

Authors:  Phillipo L Chalya; Mabula D McHembe; Joseph B Mabula; Peter F Rambau; Hyasinta Jaka; Mheta Koy; Eliasa Mkongo; Nestory Masalu
Journal:  World J Surg Oncol       Date:  2013-04-18       Impact factor: 2.754

4.  Patterns and presentations of colorectal cancer at Komfo-Anokye teaching hospital Kumasi, Ghana.

Authors:  Francis Agyemang-Yeboah; Joseph Yorke; Christian Obirikorang; Emmanuella Nsenbah Batu; Emmanuel Acheampong; Emmanuel Amankwaa Frempong; Enoch Odame Anto; Bright Amankwaa
Journal:  Pan Afr Med J       Date:  2017-10-06

5.  Patterns of Early-Onset Colorectal Cancer Among Nigerians and African Americans.

Authors:  Andreana N Holowatyj; Aishatu Suleiman Maude; Halimatu Sadiya Musa; Ahmed Adamu; Sani Ibrahim; Adamu Abdullahi; Muhammad Manko; Sirajo Mohammed Aminu; Abdullahi Mohammed; John Idoko; Yahaya Ukwenya; John Carpten; Paulette D Chandler; Heather Hampel; Mohammed Faruk
Journal:  JCO Glob Oncol       Date:  2020-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.